Visual function tests as potential biomarkers in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 13, 2011, Pages 9457-9469

  Dimitrov, Peter N ^a   Robman, Liubov D ^a   Varsamidis, Mary ^a   Aung, Khin Zaw ^a   Makeyeva, Galina A ^a   Guymer, Robyn H ^a   Vingrys, Algis J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLUE LIGHT; CONTROLLED STUDY; DARK ADAPTATION; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; HUMAN; LIGHT STRESS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RED LIGHT; REPRODUCIBILITY; RETINA CONE; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD; SENSITIVITY AND SPECIFICITY; VISION TEST; VISUAL ACUITY; VISUAL THRESHOLD; COLOR VISION; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; PSYCHOPHYSICS; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA;

AGED; COLOR VISION; DARK ADAPTATION; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; PHOTIC STIMULATION; PSYCHOPHYSICS; REPRODUCIBILITY OF RESULTS; VISION TESTS; VISUAL ACUITY;

EID: 84856328051     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-7043     Document Type: Article

References (79)

1. Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484-1498.
2. Sunness JS, Massof RW, Johnson MA, et al. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmology. 1989;96:375-381.
3. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450-1460.
4. VanNewkirk MR, Nanjan MB, Wang JJ, et al. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology. 2000;107:1593-1600.
5. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108:697-704.
6. Bird AC. Therapeutic targets in age-related macular disease. J Clin Invest. 2010;120:3033-3041.
7. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2:552-577.
8. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58:353-363.
9. Guymer R, Luthert P, Bird A. Changes in Bruch's membrane and related structures with age. Prog Retin Eye Res. 1999;18:59-90.
10. Sobrin L, Reynolds R, Yu Y, et al. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol. 2011;151:345-352.
11. Ting AY, Lee TK, MacDonald IM. Genetics of age-related macular degeneration. Curr Opin Ophthalmol. 2009;20:369-376.
12. Stanga PE, Bird AC. Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. Int Ophthalmol. 2001;23:191-197.
13. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496-500.
14. Lois N, Owens SL, Coco R, et al. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol. 2002;133:341-349.
15. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182-191.
16. Siderov J, Tiu AL. Variability of measurements of visual acuity in a large eye clinic. Acta Ophthalmol Scand. 1999;77:673-676.
17. Thibos LN, Bradley A. New methods for discriminating neural and optical losses of vision. Optom Vis Sci. 1993;70:279-287.
18. Jackson GR, Owsley C. Scotopic sensitivity during adulthood. Vision Res. 2000;40:2467-2473.
19. Jackson GR, Owsley C, Cordle EP, Finley CD. Aging and scotopic sensitivity. Vision Res. 1998;38:3655-3662.
20. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev. 2002;1:381-396.
21. Jackson GR, Owsley C, McGwin G Jr. Aging and dark adaptation. Vision Res. 1999;39:3975-3982.
22. Sloane ME, Owsley C, Jackson CA. Aging and luminance-adaptation effects on spatial contrast sensitivity. J Opt Soc Am A. 1988;5: 2181-2190.
23. Hogg RE, Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res. 2006;25: 249-276.
24. Brown B, Adams AJ, Coletta NJ, Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthalmic Physiol Opt. 1986a;6:81-84.
25. Cheng AS, Vingrys AJ. Visual losses in early age-related maculopathy. Optom Vis Sci. 1993;70:89-96.
26. Curcio CA, Owsley C, Jackson GR. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41:2015-2018.
27. Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci. 2008;49:55-65.
28. Eisner A, Fleming SA, Klein ML, Mauldin WM. Sensitivities in older eyes with good acuity: eyes whose fellow eye has exudative AMD. Invest Ophthalmol Vis Sci. 1987;28:1832-1837.
29. Mayer MJ, Ward B, Klein R, et al. Flicker sensitivity and fundus appearance in pre-exudative age-related maculopathy. Invest Ophthalmol Vis Sci. 1994;35:1138-1149.
30. Neelam K, Nolan J, Chakravarthy U, Beatty S. Psychophysical function in age-related maculopathy. Surv Ophthalmol. 2009;54: 167-210.
31. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:267-273.
32. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196-1202.
33. Phipps JA, Guymer RH, Vingrys AJ. Temporal sensitivity deficits in patients with high-risk drusen. Aust N Z J Ophthalmol. 1999;27: 265-267.
34. Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age-related maculopathy. Invest Ophthalmol Vis Sci. 2003;44: 2277-2283.
35. Scholl HP, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci. 2004;45:574-583.
36. Chen JC, Fitzke FW, Pauleikhoff D, Bird AC. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci. 1992;33:334-340.
37. Haegerstrom-Portnoy G. Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment? J Opt Soc Am A. 1988;5:2140-2144.
38. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function: eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1991;32:8-20.
39. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Monitoring retinal function in early age-related maculopathy: visual performance after 1 year. Eye (Lond). 2005;19:1169-1177.
40. Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci. 1997;38:469-477.
41. Brown B, Garner LF. Effects of luminance on contrast sensitivity in senile macular degeneration. Am J Optom Physiol Opt. 1983;60: 788-793.
42. Mei M, Leat SJ. Suprathreshold contrast matching in maculopathy. Invest Ophthalmol Vis Sci. 2007;48:3419-3424.
43. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Mid-frequency loss of foveal flicker sensitivity in early stages of age-related maculopathy. Invest Ophthalmol Vis Sci. 1992a;33:3136-3142.
44. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Foveal flicker sensitivity discriminates ARM-risk from healthy eyes. Invest Ophthalmol Vis Sci. 1992;33:3143-3149.
45. Hogan MJ. Role of the retinal pigment epithelium in macular disease. Trans Am Acad Ophthalmol Otolaryngol. 1972;76: 64-80.
46. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 1996; 37:1236-1249.
47. Lamb TD, Pugh EN Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004;23(3):307-380.
48. Pianta M, Kalloniatis M. Characterisation of dark adaptation in human cone pathways: an application of the equivalent background hypothesis. J Physiol. 2000;528:591-608.
49. Collins M, Brown B. Glare recovery and its relation to other clinical findings in age-related maculopathy. Clin Vision Sci. 1989;4:155-163.
50. Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:3355-3360.
51. Garhofer G, Zawinka C, Resch H, et al. Diffuse luminance flicker increases blood flow in major retinal arteries and veins. Vision Res. 2004;44:833-838.
52. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and agerelated macular degeneration. The International ARM Epidemiological Study Group. Survey of Ophthalmology. 1995;39:367-374.
53. Taylor HR, West SK. The clinical grading of lens opacities. Aust N Z J Ophthalmol. 1989;17:81-86.
54. Aung KZ, Robman L, Chong EW, et al. Non-mydriatic digital macular photography: how good is the second eye photograph? Ophthalmic Epidemiol. 2009;16:254-261.
55. Brown B, Lovie-Kitchin J. Temporal function in age related maculopathy. Clin Exp Optom. 2009;70:112-116.
56. Metha A, Vingrys AJ, Badcock D. Calibration of a colour monitor for visual psychophysics. Behav Res Meth Instrum Comput. 1993; 25:371-383.
57. Rosati P, Bartolozzi F, Guariglia L. Intra-and interobserver repeatability of femur length measurement in early pregnancy. Ultrasound Obstet Gynecol. 2004;23:599-601.
58. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
59. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143:29-36.
60. Motulsky HJ. Prism 4 Statistics Guide: Statistical Analyses for Laboratory and Clinical Researchers. San Diego, CA: GraphPad Software Inc., 2003.
61. Linden A. Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract. 2006;12:132-139.
62. Gravetter FJ, Wallnau LB. Statistics for the Behavioral Sciences. St. Paul: West Publishing Company; 1992.
63. Gittings NS, Fozard JL. Age related changes in visual acuity. Exp Gerontol. 1986;21:423-433.
64. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34:3278-3296.
65. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Functional loss in early age-related maculopathy: the ischaemia postreceptoral hypothesis. Eye. 2007;21:689-696.
66. Formaz F, Riva CE, Geiser M. Diffuse luminance flicker increases retinal vessel diameter in humans. Curr Eye Res. 1997;16:1252-1257.
67. Shakoor A, Blair NP, Mori M, Shahidi M. Chorioretinal vascular oxygen tension changes in response to light flicker. Invest Ophthalmol Vis Sci. 2006;47:4962-4965.
68. Owsley C, McGwin G Jr, Jackson GR, Kallies K, Clark M. Cone-and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology. 2007;114:1728-1735.
69. Brown B, Tobin C, Roche N, Wolanowski A. Cone adaptation in agerelated maculopathy. Am J Optom Physiol Opt. 1986b;63:450-454.
70. Bartlett H, Davies LN, Eperjesi F. Reliability, normative data, and the effect of age-related macular disease on the Eger Macular Stressometer photostress recovery time. Ophthalmic Physiol Opt. 2004;24:594-599.
71. Haimovici R, Owens SL, Fitzke FW, Bird AC. Dark adaptation in age-related macular degeneration: relationship to the fellow eye. Graefes Arch Clin Exp Ophthalmol. 2002;240:90-95.
72. Steinmetz RL, Haimovici R, Jubb C, Fitzke FW, Bird AC. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol. 1993;77:549-554.
73. Collins M, Brown B. Glare recovery and age-related maculopathy. Clin Vision Sci. 1989;4:145-153.
74. Curcio CA. Photoreceptor topography in ageing and age-related maculopathy. Eye (Lond). 2001;15:376-383.
75. Feigl B, Cao D, Morris CP, Zele AJ. Persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision. Invest Ophthalmol Vis Sci. 2011;52:1145-1150.
76. Frumkes TE, Sekuler MD, Barris MC, Reiss EH, Chalupa LM. Rodcone interaction in human scotopic vision, I: temporal analysis. Vision Res. 1973;13:1269-1282.
77. MacLeod DI. Rods cancel cones in flicker. Nature. 1972;235:173-174.
78. Goldberg SH, Frumkes TE, Nygaard RW. Inhibitory influence of unstimulated rods in the human retina: evidence provided by examining cone flicker. Science. 1983;221:180-182.
79. Vingrys AJ, Pianta MJ. A new look at threshold estimation algorithms for automated static perimetry. Optom Vis Sci. 1999;76: 588-595.